State Street SPDR S&P Biotech ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 127.46
成立日期: 31/01/2006
 
分析
市值分佈:
65.29%
大市值
29.87%
中市值
7.17%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:54) 總持有投資項目: 145  
0%
 
100%
     10大 (16.71%)
代號 名稱 佔比% 持有日期
CGONCG Oncology1.3027/02/2026
INCYIncyte Corp1.3027/02/2026
ALKSAlkermes plc1.2827/02/2026
CRSPCRISPR Therapeutics AG1.2727/02/2026
UTHRUnited Therapeutics Corp1.2727/02/2026
IONSIonis Pharmaceuticals1.2627/02/2026
CYTKCytokinetics1.2627/02/2026
ABBVABBVIE1.2527/02/2026
IBRXImmunityBio1.2427/02/2026
EXASExact Sciences Corp1.2427/02/2026
RNAMAvidity Biosciences Inc.1.2431/01/2026
PTGXProtagonist Therapeutics1.2327/02/2026
TGTXTG Therapeutics1.2027/02/2026
SRRKScholar Rock Holding Corp1.2027/02/2026
TWSTTwist Bioscience Corp1.1227/02/2026
KYMRKymera Therapeutics1.1227/02/2026
PTCTPTC Therapeutics1.1227/02/2026
ARWRArrowhead Pharmaceuticals1.1227/02/2026
BBIOBridgeBio Pharma1.1127/02/2026
VKTXViking Therapeutics1.1027/02/2026
  1   2    3    4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.